This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Apo-Sertraline (2017-01-13)
- Starting date:
- January 13, 2017
- Posting date:
- January 16, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-61808
Reason
Affected Lot (Apo-Sertraline 50 mg) may contain units of sertraline 25 mg.
Depth of distribution
Wholesalers and Retailers - Canada (AB, BC, MB, NB, NF, NS, ON, QC, and SK)
Affected products
Apo-Sertraline
DIN, NPN, DIN-HIM
DIN 02238281Dosage form
Capsule
Strength
50 mg Sertraline (Sertraline Hydrochloride)
Lot or serial number
MV1007
Companies
- Recalling Firm
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
- Marketing Authorization Holder
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA